Coronavirus Testing in the Outpatient Setting
Customize your policy alerts
Sign up for Blue Cross Blue Shield - Texas Policy RPLAB057 alerts
Get alerted when Policy RPLAB057 changes without checking for updates manually.
Monitor payer policy activity
This policy governs reimbursement for SARS-CoV-2 and related coronavirus testing performed for medical decision making in the outpatient setting. It applies to providers submitting claims to Blue Cross Blue Shield of Texas, subject to the member’s plan documents and provider contract.
The December 4, 2026 update revised Reimbursement Information Notes 1, 2, and 3 to align with updated CDC definitions for COVID-19, MIS-C, and MIS-A.
The July 25, 2025 update added NAAT as an acceptable test option for MIS-A and MIS-C and revised the related language for clarity.
The July 25, 2025 update revised testing frequency to include testing once every 48 hours.
The July 25, 2025 update removed the provision for asymptomatic individuals before immunosuppressive or aerosol-producing procedures.
The July 25, 2025 update removed items addressing whole genome sequencing and other numbered reimbursement provisions, including items 6, 7, 8, and 10 as described in the history.
The July 25, 2025 update removed codes 86318, 86790, 87428, 87631, 87632, 87633, 87797, 87799, 0115U, 0202U, 0223U, 0225U, and C9803.
The December 4, 2026 update revised the policy references.
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.